| Harrison Courie, MD | |
|
801 Ostrum St, Bethlehem, PA 18015-1000 | |
| (484) 526-4903 | |
| Not Available |
| Full Name | Harrison Courie |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 6 Years |
| Location | 801 Ostrum St, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003309121 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MT216196 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Miners Memorial Hospital | Coaldale, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Luke's Physician Group Inc | 6709798333 | 1739 |
News Archive
Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center in collaboration with Developmental Disabilities Health Alliance of New York and Community Resource Center for the Developmentally Disabled, Inc., have received a $2.4 million grant to integrate medical and mental healthcare for children and adults with intellectual and developmental disabilities (IDD).
Cardiologists at the University of Connecticut Health Center have identified a protein fragment that when detected in the blood can be a predictor of heart attack.
A new partnership to search for cancer-fighting drugs combines compound-identification and screening expertise at the University of Mississippi's National Center for Natural Products Research with the drug development and clinical-trials capabilities at the University of Mississippi Medical Center Cancer Institute.
When a patient afflicted with schizophrenia hears inner voices something is taking place inside the brain that prevents the individual from perceiving real voices. A simple electronic application may help the patient learn to shift focus.
Nycomed and Merck & Co., Inc. (based in Whitehouse Station, New Jersey and known as MSD outside the USA and Canada) today announced that they have entered into a co-promotion agreement for Canada and certain European countries for the commercialization of Daxas® (roflumilast), an investigational once-daily tablet for patients with chronic obstructive pulmonary disease (COPD). In addition, the two companies have signed an exclusive distribution agreement for the commercialization of Daxas® in the United Kingdom.
› Verified 3 days ago
| Entity Name | St Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center in collaboration with Developmental Disabilities Health Alliance of New York and Community Resource Center for the Developmentally Disabled, Inc., have received a $2.4 million grant to integrate medical and mental healthcare for children and adults with intellectual and developmental disabilities (IDD).
Cardiologists at the University of Connecticut Health Center have identified a protein fragment that when detected in the blood can be a predictor of heart attack.
A new partnership to search for cancer-fighting drugs combines compound-identification and screening expertise at the University of Mississippi's National Center for Natural Products Research with the drug development and clinical-trials capabilities at the University of Mississippi Medical Center Cancer Institute.
When a patient afflicted with schizophrenia hears inner voices something is taking place inside the brain that prevents the individual from perceiving real voices. A simple electronic application may help the patient learn to shift focus.
Nycomed and Merck & Co., Inc. (based in Whitehouse Station, New Jersey and known as MSD outside the USA and Canada) today announced that they have entered into a co-promotion agreement for Canada and certain European countries for the commercialization of Daxas® (roflumilast), an investigational once-daily tablet for patients with chronic obstructive pulmonary disease (COPD). In addition, the two companies have signed an exclusive distribution agreement for the commercialization of Daxas® in the United Kingdom.
› Verified 3 days ago
| Entity Name | Gslpg, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366006702 PECOS PAC ID: 7810226875 Enrollment ID: O20190917001763 |
News Archive
Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center in collaboration with Developmental Disabilities Health Alliance of New York and Community Resource Center for the Developmentally Disabled, Inc., have received a $2.4 million grant to integrate medical and mental healthcare for children and adults with intellectual and developmental disabilities (IDD).
Cardiologists at the University of Connecticut Health Center have identified a protein fragment that when detected in the blood can be a predictor of heart attack.
A new partnership to search for cancer-fighting drugs combines compound-identification and screening expertise at the University of Mississippi's National Center for Natural Products Research with the drug development and clinical-trials capabilities at the University of Mississippi Medical Center Cancer Institute.
When a patient afflicted with schizophrenia hears inner voices something is taking place inside the brain that prevents the individual from perceiving real voices. A simple electronic application may help the patient learn to shift focus.
Nycomed and Merck & Co., Inc. (based in Whitehouse Station, New Jersey and known as MSD outside the USA and Canada) today announced that they have entered into a co-promotion agreement for Canada and certain European countries for the commercialization of Daxas® (roflumilast), an investigational once-daily tablet for patients with chronic obstructive pulmonary disease (COPD). In addition, the two companies have signed an exclusive distribution agreement for the commercialization of Daxas® in the United Kingdom.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Harrison Courie, MD 5554 Richmond Rd, Bedford Hts, OH 44146-1862 Ph: (216) 704-0363 | Harrison Courie, MD 801 Ostrum St, Bethlehem, PA 18015-1000 Ph: (484) 526-4903 |
News Archive
Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center in collaboration with Developmental Disabilities Health Alliance of New York and Community Resource Center for the Developmentally Disabled, Inc., have received a $2.4 million grant to integrate medical and mental healthcare for children and adults with intellectual and developmental disabilities (IDD).
Cardiologists at the University of Connecticut Health Center have identified a protein fragment that when detected in the blood can be a predictor of heart attack.
A new partnership to search for cancer-fighting drugs combines compound-identification and screening expertise at the University of Mississippi's National Center for Natural Products Research with the drug development and clinical-trials capabilities at the University of Mississippi Medical Center Cancer Institute.
When a patient afflicted with schizophrenia hears inner voices something is taking place inside the brain that prevents the individual from perceiving real voices. A simple electronic application may help the patient learn to shift focus.
Nycomed and Merck & Co., Inc. (based in Whitehouse Station, New Jersey and known as MSD outside the USA and Canada) today announced that they have entered into a co-promotion agreement for Canada and certain European countries for the commercialization of Daxas® (roflumilast), an investigational once-daily tablet for patients with chronic obstructive pulmonary disease (COPD). In addition, the two companies have signed an exclusive distribution agreement for the commercialization of Daxas® in the United Kingdom.
› Verified 3 days ago
Dr. Melanie Kay Turock, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 801 Ostrum St, Dept. Of Emergency Medicine, Bethlehem, PA 18015 Phone: 610-954-4903 | |
Stephanie A. Cohrac, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-2888 Fax: 484-884-2885 | |
Kelly Hay, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 973-769-1524 | |
Brandon Merkert, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4000 | |
Joseph Smoot, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4903 | |
Ari Ron Malka, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 610-954-3383 Fax: 610-954-6500 |